Insulin Analog [EPC]

165304 reported adverse events

Drugs of this class: INSULIN LISPRO INSULIN GLARGINE INSULIN DETEMIR INSULIN GLARGINE AND LIXISENATIDE INSULIN GLULISINE INSULIN LISPRO-AABC

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 36298
1 BLOOD GLUCOSE DECREASED 9064
2 DRUG INEFFECTIVE 8907
3 NAUSEA 7270
4 INCORRECT DOSE ADMINISTERED 6429
5 HYPOGLYCAEMIA 5956
6 MALAISE 5460
7 FATIGUE 5207
8 DYSPNOEA 5161
9 DIARRHOEA 5044
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTERCEPTED PRODUCT SELECTION ERROR 248 0.5427
1 HYPOGLYCAEMIA UNAWARENESS 158 0.5163
2 ANTI-INSULIN ANTIBODY POSITIVE 91 0.4483
3 HYPOGLYCAEMIC UNCONSCIOUSNESS 632 0.3803
4 BLOOD KETONE BODY 89 0.3423
5 DIABETIC RETINOPATHY 701 0.3226
6 HYPOGLYCAEMIC SEIZURE 227 0.3076
7 INSULIN RESISTANCE 342 0.2990
8 DEVICE OPERATIONAL ISSUE 500 0.2959
9 BLOOD GLUCOSE INCREASED 36298 0.2785
See all enriched reactions for Insulin Analog [EPC]